Science & Technology
Preclinical Development of LCTG-001, a Human Secretory IgA Replacement Therapy for CVID Patients
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R42AI188865-01
Award Ceiling
$305K
Award Floor
$305K
Close Date
Dec 31, 2025
Total Funding
$305K
Expected Awards
1
Posted Date
Jan 24, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R42AI188865-01
Description
STTR Phase Phase I award: "Preclinical Development of LCTG-001, a Human Secretory IgA Replacement Therapy for CVID Patients" awarded to LACTIGA US INC. in North Brunswick, New Jersey. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $304,629. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.